BTMD NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

biote Corp · Healthcare · Medical Care Facilities

Open interactive chart View report data Download investor PDF
Latest close 2.28 USD
-6.2% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 9.5% above the Trend Line and sits at 29.0% of its 52-week range. The latest completed week returned -6.2%, after a 27.4% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers. The latest news-sentiment score is 49/100. Near-term considerations: volume confirmation is below normal; earnings are due in 7d.

Setup score 36 out of 100
Latest Close 2.28 USD 24 Jul 2026
1W Return -6.2% latest completed week
4W Return 27.4% short-term follow-through
12W Return 4.1% quarterly tape
Trend Breadth 1.9% 1 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • The trend backdrop is active with a 1-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
  • The latest week was a sharp negative move.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -6.2% Latest completed week; four-week move 27.4%. Indicator stack 5/70 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 49/100 59 relevant articles in the latest sentiment read. Event risk 7d Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 9.5% above the Trend Line and sits at 29.0% of its 52-week range. The latest completed week returned -6.2%, after a 27.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2812-week average 0.25

12-week confirmation

Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.28Current proprietary activity-pressure read.
Buy signals2Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 27.4% over four weeks, 4.1% over 12 weeks, and -47.2% over one year. The current trend has remained active for 1 consecutive weeks.

Performance by holding period

1W-6.2%
4W27.4%
12W4.1%
26W3.2%
52W-47.2%
Active trend streak1 weeks
Active weeks in one year1
Trend breadth1.9%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.05Latest activity-pressure read.
Pressure change15.8%Four-week change in activity pressure.
Leadership-15.47Latest relative-leadership reading.
RS change61.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 94% Model confidence 90%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength88/100Blend of value, momentum, and quality. Underlying universe rank 13; rank 1 is best.
Value97/100Relative valuation strength. Underlying universe rank 4; rank 1 is best.
Quality93/100Profitability and accounting quality. Underlying universe rank 8; rank 1 is best.
Momentum5/100Medium-term price momentum. Underlying universe rank 96; rank 1 is best.
Growth3/100Revenue and earnings growth. Underlying universe rank 98; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework98/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
4.4x
Price divided by trailing earnings.
Price / sales
0.4x
Market value relative to trailing revenue.
EV / EBITDA
4.8x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
20.7%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
70.1%
Gross profit retained from each unit of revenue.
Operating margin
17.8%
Operating profit retained from revenue.
Free-cash-flow margin
19.9%
Free cash flow generated from revenue.
Return on invested capital
56.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-5.6%
Latest one-year revenue growth.
EPS growth
-28.4%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-27.9%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.1%
Cash dividends relative to market value.
Buyback yield
6.2%
Net share repurchases relative to market value.
Shareholder yield
8.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity15 / 1

15 acquisitions and 1 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment49/100

Weighted news tone is neutral across 59 relevant articles.

6 positive · 45 neutral · 8 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings7dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-52.0%Distance below the 52-week high.
13-week volatility10.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2612 weeks finished lower.
Best week+39.6%Week of 17 Apr.
Worst week-25.3%Week of 13 Mar.
Latest week-6.2%Week of 24 Jul.

Shape of recent returns

Strong gains9
Modest gains4
Flat weeks1
Modest losses3
Sharp losses9
Recent vol10.7%13-week weekly-return volatility.
Base vol10.8%52-week weekly-return volatility.
Up/down split24/27Count of positive and negative weeks in the 52-week window.
Average skew7.5% / -7.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape27/100

Trend, activity pressure, participation, and risk combine to a 27/100 tape read.

 Indicator analysis36/100

Latest 12-week confirmation: trend 1/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.28; No reversal markers Factors72/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Tiny Titans rank 64; Buyback Yield rank 10; Small Cap Core rank 3 SVQF98/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 17.0 of 726 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment49/100

Weighted news tone is neutral across 59 relevant articles.

BlackRock (BTMD holder) discloses 359,732 Biote Corp shares in 13G/A filing Insiders15 / 1

15 acquisitions and 1 disposals in the latest 180-day insider tape.

 Earnings7d

Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20262.28 USD-6.2%2.08 USD4.33 USD1.05-15.47729.6KOn
17 Jul 20262.43 USD4.3%2.09 USD4.36 USD1.08-13.181.3MOff
10 Jul 20262.33 USD7.4%2.11 USD4.40 USD0.92-21.60909.2KOff
3 Jul 20262.17 USD21.2%2.12 USD4.43 USD0.94-27.091.8MOff
26 Jun 20261.79 USD-20.8%2.13 USD4.45 USD0.91-40.594.5MOff
19 Jun 20262.26 USD-8.1%2.16 USD4.48 USD0.83-29.99740.1KOff
12 Jun 20262.46 USD5.1%2.17 USD4.51 USD0.80-23.281.1MOff
5 Jun 20262.34 USD17.0%2.18 USD4.53 USD0.73-26.541.0MOff
29 May 20262.00 USD0.5%2.19 USD4.55 USD0.75-41.03938.0KOff
22 May 20261.99 USD1.0%2.22 USD4.58 USD0.82-40.621.1MOff
15 May 20261.97 USD-9.6%2.25 USD4.60 USD0.87-41.581.3MOff
8 May 20262.18 USD-0.5%2.28 USD4.62 USD0.92-36.871.0MOff
1 May 20262.19 USD-3.9%2.30 USD4.65 USD0.57-34.43633.1KOff
24 Apr 20262.28 USD2.7%2.32 USD4.67 USD0.17-31.71773.2KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.